Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis

J Neuroimmunol. 2020 Feb 15:339:577108. doi: 10.1016/j.jneuroim.2019.577108. Epub 2019 Nov 7.

Abstract

Cerebrospinal fluid (CSF) free light chains (FLC) may be an alternative biomarker to oligoclonal bands (OCB) in multiple sclerosis (MS). Herein, we compared the diagnostic accuracy of CSF OCB and FLC and we tested the prognostic value of FLC in a cohort of 64 MS patients and 106 controls. A κ-index >7.83 was more sensitive but less specific than OCB in discriminating MS patients from controls. Additionally, a κ-index >10.61 performed better than OCB in the discrimination between MS and controls with inflammatory neurological diseases (p < .001). In clinically isolated syndrome (CIS) patients, a κ-index >10.61 significantly predicted time to conversion to MS (p = .020). κ-index might be a valid alternative to OCB as a diagnostic biomarker for MS and might also be a prognostic marker in CIS.

Keywords: Biomarker; Cerebrospinal fluid; Free light chains; Kappa index; Multiple sclerosis.

MeSH terms

  • Adult
  • Aged
  • Biomarkers / cerebrospinal fluid
  • Cohort Studies
  • Female
  • Humans
  • Immunoglobulin Light Chains / cerebrospinal fluid*
  • Male
  • Middle Aged
  • Multiple Sclerosis / cerebrospinal fluid*
  • Multiple Sclerosis / diagnosis*
  • Oligoclonal Bands / cerebrospinal fluid*

Substances

  • Biomarkers
  • Immunoglobulin Light Chains
  • Oligoclonal Bands